Insights

HELIX alpha is further strengthening its European platform and expanding the specialist capabilities it offers across Life Science Real Estate. As of 1 October 2026, Patrick Schlump will join HELIX alpha as Managing Partner and shareholder, taking a leading role in Fund Management, Client Relations and Equity Raising. Most recently with France-based Praemia REIM, Patrick brings extensive experience in European investment and fund management. He and HELIX alpha founder and CEO

Martin Eberhardt FRICS, CEO & Founder of HELIX alpha, will participate in a panel discussion on the specific challenges of valuing Social Infrastructure, including Life Science Real Estate, at the RICS Valuation Conference in Frankfurt am Main on 22 September 2026. The valuation of Life Science Real Estate presents particular challenges for valuers and investors. The European market is still comparatively young, with a limited number of investment transactions and reliable co

February 2026 I Corporate News We are pleased to announce the appointment of our Country and Regional Representatives in France, Spain and the Nordics, marking another important step in the expansion of HELIX alpha’s European Life Science Real Estate investment management platform. Guided by our principle “Think European, Act Local”, we are strengthening local market access, cluster proximity and execution capabilities across key European ecosystems. Together with our interdi

December 2026 I Corporate News We are truly excited to share a major milestone for HELIX alpha. We have appointed an exceptional, interdisciplinary Advisory Board - an important step in strengthening our company’s development and our ability to navigate the young and complex asset class of life science real estate. We welcome four outstanding experts as voting members of our Investment & Risk Committee: Prof. Dr. Thomas Glatte – Chair of the board, real estate leader with t

November 2025 | Company News HELIX alpha announces the launch of its European investment platform focused on Life Science Real Estate. The company combines expertise in real estate, capital markets and life sciences to provide institutional investors with access to a highly specialized asset class. Download the full press release: